The SIAH1–HIPK2–p53ser46 Damage Response Pathway is Involved in Temozolomide-Induced Glioblastoma Cell Death (original) (raw)
Bernd Kaina
2019, Molecular Cancer Research
visibility
…
description
14 pages
link
1 file
Distinct molecular mechanisms of acquired resistance to temozolomide in glioblastoma cells
Ana-Maria Florea
Journal of Neurochemistry, 2012
View PDFchevron_right
MGMTGene Silencing and Benefit from Temozolomide in Glioblastoma
Johan Kros
The New England Journal of Medicine, 2005
View PDFchevron_right
Inhibitors of GLUT/SLC2A Enhance the Action of BCNU and Temozolomide against High-Grade Gliomas
Francesca Garello
Neoplasia, 2017
View PDFchevron_right
Protracted Adjuvant Temozolomide in Glioblastoma Multiforme
Dina Salem
Journal of Cancer Therapy, 2015
View PDFchevron_right
Extended-schedule dose-dense temozolomide in refractory gliomas
Miguel Angel Garcia Gil
Journal of Neuro-Oncology, 2009
View PDFchevron_right
Temozolomide resistance in glioblastoma occurs by miRNA-9-targeted PTCH1, independent of sonic hedgehog level
Jessian Munoz
Oncotarget, 2015
View PDFchevron_right
Glioma Cell Biology
Aleksi Šedo
2014
View PDFchevron_right
Inhibition of prolyl 4-hydroxylase, beta polypeptide (P4HB) attenuates temozolomide resistance in malignant glioma via the endoplasmic reticulum stress response (ERSR) pathways
Cf Fung
Neuro-Oncology, 2013
View PDFchevron_right
Tumor mutational burden and purity adjustment before and after treatment with temozolomide in 27 paired samples of glioblastoma: a prospective study
Jannick Brennum
Molecular Oncology, 2021
View PDFchevron_right
Glioblastoma: Therapeutic challenges, what lies ahead
Luciana Romão
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2012
View PDFchevron_right
Loading Preview
Sorry, preview is currently unavailable. You can download the paper by clicking the button above.
Temozolamide-Associated Pancytopenia in a Patient with Glioblastoma Multiforme
Kübra BOZKURT
International Journal of Case Reports, 2019
View PDFchevron_right
KCa3.1 channel inhibition sensitizes malignant gliomas to temozolomide treatment
Davide Ragozzino
Oncotarget, 2016
View PDFchevron_right
Are There Thresholds in Glioblastoma Cell Death Responses Triggered by Temozolomide?
Bernd Kaina
International Journal of Molecular Sciences
View PDFchevron_right
Temozolomide enhances herpes simplex virus thymidine kinase/ganciclovir therapy of malignant glioma
Ting-Chao Chou
Cancer Gene Therapy, 2001
View PDFchevron_right
Tumor response of temozolomide in combination with morphine in a xenograft model of human glioblastoma
Giacomo Signorino
Oncotarget, 2017
View PDFchevron_right
Randomized Study of Postoperative Radiotherapy and Simultaneous Temozolomide without Adjuvant Chemotherapy for Glioblastoma
Peter Frommolt
Strahlentherapie und Onkologie, 2008
View PDFchevron_right
Evaluation of novel imidazotetrazine analogues designed to overcome temozolomide resistance and glioblastoma regrowth
Jarkko Rautio
Molecular Cancer Therapeutics, 2014
View PDFchevron_right
The kinase inhibitor SI113 induces autophagy and synergizes with quinacrine in hindering the growth of human glioblastoma multiforme cells
nicola perrotti
Journal of Experimental & Clinical Cancer Research
View PDFchevron_right
Acquisition of Temozolomide Chemoresistance in Gliomas Leads to Remodeling of Mitochondrial Electron Transport Chain
Susan Nozell
Journal of Biological Chemistry, 2010
View PDFchevron_right
Multifaceted Resistance of Gliomas to Temozolomide1
Demetrius Kokkinakis
2002
View PDFchevron_right
Incidence of early pseudo‐progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide
Martin Van Den Bent
Cancer, 2008
View PDFchevron_right
Multifaceted resistance of gliomas to temozolomide
Demetrius Kokkinakis
Clinical cancer …, 2002
View PDFchevron_right
Combination hyperbaric oxygen and temozolomide therapy in c6 rat glioma model
AKIN SAVAŞ TOKLU
Acta Cirurgica …, 2012
View PDFchevron_right
Targeting c-IAP1, c-IAP2, and Bcl-2 Eliminates Senescent Glioblastoma Cells Following Temozolomide Treatment
Bernd Kaina
Cancers, 2021
View PDFchevron_right
Role of Inflammation and Oxidative Stress Mediators in Gliomas
M'Hammed Aguennouz
Cancers, 2010
View PDFchevron_right
Epigenomic perturbation of novelEGFRenhancers reduces the proliferative and invasive capacity of glioblastoma and increases sensitivity to temozolomide
Itzel Nissen
bioRxiv (Cold Spring Harbor Laboratory), 2023
View PDFchevron_right
Cancer- related protein profile of patient-derived and commercial glioblastoma cell lines exposed to Temozolomide
Anna Bielecka-Wajdman
View PDFchevron_right
Involvement of PI3K Pathway in Glioma Cell Resistance to Temozolomide Treatment
Iwona Wertel
International Journal of Molecular Sciences
View PDFchevron_right
Effect of temozolomide on the U-118 glioma cell line
Helena Carvalheiro
Oncology Letters, 2011
View PDFchevron_right
Signaling pathways and therapeutic approaches in glioblastoma multiforme (Review)
Oleg Kit
International Journal of Oncology
View PDFchevron_right
The Effect of Silibinin in Enhancing Toxicity of Temozolomide and Etoposide in p53 and PTEN-mutated Resistant Glioma Cell Lines
Karam Soliman
Anticancer research, 2015
View PDFchevron_right
BiologyMedicineMolecular Biology Cancer